<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="R0 of SARS was 2 and 1.3 for the 2009" exact="H1N1 Influenza" post="[26].The mortality rate for COVID-19 ranges between 2 and"/>
 <result pre="of SARS was 2 and 1.3 for the 2009 H1N1" exact="Influenza" post="[26].The mortality rate for COVID-19 ranges between 2 and"/>
 <result pre="RNA-chain terminator by binding to RNA dependent RNA polymerase (RdRP)." exact="Ebola" post="200Â mg intravenously (IV) on day 1 followed by"/>
 <result pre="[45], [46], [47] Oseltamivir(1999) Antiviral; Neuraminidase inhibitor Inhibits viral replication." exact="Influenza" post="75Â mg orally twice a day for 5Â days"/>
 <result pre="vitro. Also showed antiviral activity in an animal model for" exact="SARS-CoV infection" post="Limited data available. [57], [58] Hydroxychloroquine / chloroquine (HCQ/CQ)"/>
 <result pre="of an adenosine analog, was originally developed to combat the" exact="Ebola" post="outbreak in 2014. It has been highly touted as"/>
 <result pre="inhibitor. It is used in China for the treatment of" exact="Influenza" post="and is capable of blocking the replication of other"/>
 <result pre="In mice, camostat mesylate showed a 60% survival rate following" exact="SARS-CoV infection," post="at dose concentrations similar to that in humans [58]."/>
 <result pre="completion date of March 30, 2021. 11 Non-Pharmacological therapies for" exact="Covid-19" post="11.1 Immunoglobulin therapy 11.1.1 Convalescent plasma therapy (CP) Inducing"/>
 <result pre="] NCT04343092 Efficacy of Ivermectin as Add on Therapy in" exact="COVID19" post="Patients Experimental: Ivermectin (IVM) 12Â mg /weeklyÂ +Â Hydroxychloroquin"/>
 <result pre="] NCT04342650 Chloroquine Diphosphate in the Prevention of SARS in" exact="Covid-19" post="Infection (CloroCOVID19II) Active Comparator: InterventionCQ 450Â mg twice daily"/>
 <result pre="Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition" exact="Covid-19" post="Brasil II) Experimental: HydroxychloroquineÂ +Â azithromycinHydroxychloroquine [400Â mg 2Ã—/day,"/>
 <result pre="Comparator: Placebo Phase 3 Randomized; Quadruple blind 1309(â‰¥18) Incidence of" exact="COVID19" post="Disease among those who are asymptomatic at baseline [Â"/>
 <result pre="52L. Dong, S. Hu, J. Gao, Discovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19), 3 (2020). 53FurutaY.KomenoT.NakamuraT.Favipiravir (T-705), a broad spectrum inhibitor"/>
 <result pre="against SARS-CoV-2 infectionViruses122020642 81Coronavirus India: Rush for plasma therapy as" exact="Covid-19" post="cases rise, https://www.bbc.com/news/world-asia-india-53387607. Accessed 21 July 2020. 82CaoW.-C.LiuW.ZhangP.-H.ZhangF.RichardusJ.H.Disappearance of"/>
</results>
